menu
    • menu

    Company profile for Silexion Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Silexion is a biotechnology company specializing in the development of innovative solutions for targeted drug delivery and personalized medicine. Our mission is to harness advanced technologies to create therapies that improve patient outcomes and enhance the effectiveness of treatments. With a strong focus on research and development, we aim to address unmet medical needs in various therapeutic areas, ensuring that our soluti...
    Silexion is a biotechnology company specializing in the development of innovative solutions for targeted drug delivery and personalized medicine. Our mission is to harness advanced technologies to create therapies that improve patient outcomes and enhance the effectiveness of treatments. With a strong focus on research and development, we aim to address unmet medical needs in various therapeutic areas, ensuring that our solutions are both safe and effective. At Silexion, we are committed to transforming healthcare through innovation, collaboration, and a dedication to excellence in every aspect of our work.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Silexion TherapeuticsIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    2 Hama'ayan Street, Modi'in-Maccabim-Reut
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://silexion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Silexion Therapeutics to Present at NobleCon21
    Silexion Therapeutics to Present at NobleCon21

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195059/0/en/Silexion-Therapeutics-to-Present-at-Noble-Capital-Markets-21st-Annual-Emerging-Growth-Equity-Conference.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    Silexion Completes SIL204 Toxicology Studies
    Silexion Completes SIL204 Toxicology Studies

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194426/0/en/Silexion-Therapeutics-Successfully-Completes-Toxicology-Studies-for-SIL204-Next-Generation-RNA-Silencing-Therapy-Ahead-of-Phase-2-3-Clinical-Trial-in-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share
    Silexion Therapeutics Reveals Q3 Financials & Business Update
    Silexion Therapeutics Reveals Q3 Financials & Business Update

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186310/0/en/Silexion-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Silexion Therapeutics Confirms Sil204 Pan-Kras Activity
    Silexion Therapeutics Confirms Sil204 Pan-Kras Activity

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158625/0/en/Silexion-Therapeutics-Announces-Positive-New-Human-Cell-Line-Data-Confirming-Pan-KRAS-Activity-of-SIL204-Demonstrating-Up-to-99-7-Inhibition-and-First-Evidence-in-Gastric-Cancer.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Silexion Therapeutics Regains Compliance with Nasdaq LR
    Silexion Therapeutics Regains Compliance with Nasdaq LR

    25 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/25/3156303/0/en/Silexion-Therapeutics-Regains-Compliance-with-Nasdaq-Listing-Requirements.html

    GLOBENEWSWIRE
    25 Sep 2025
    Share Share
    Silexion Therapeutics Prices $6.0 Million Public Offering
    Silexion Therapeutics Prices $6.0 Million Public Offering

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148617/0/en/Silexion-Therapeutics-Announces-Pricing-of-6-0-Million-Public-Offering.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search